Management of acquired bleeding problems in cancer patients.
Cancer patients can have acquired bleeding problems for many reasons. In this review, an approach to the bleeding patient in the Emergency Department is discussed. Specific issue including coagulation defects, thrombocytopenia, platelet dysfunction, bleeding complications of specific hematological malignancies and due to anticoagulation, are discussed.
DeLoughery
Thomas G
TG
Division of Hematology, Department of Medicine, L586, Oregon Health & Science University, Portland, OR 97201-3098, USA. delought@ohsu.edu
D000925:Anticoagulants / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000209:etiology / Q000628:therapy; D001780:Blood Coagulation Tests; D004636:Emergency Service, Hospital; D015942:Factor VIIa / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy*; D006487:Hemostasis; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017713:Platelet Transfusion / Q000009:adverse effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D065227:Transfusion Reaction; D014511:Uremia / Q000150:complications
D000925:Anticoagulants; D011994:Recombinant Proteins; D006493:Heparin; C103587:recombinant FVIIa; D015942:Factor VIIa